Hawaii 2022 Regular Session

Hawaii Senate Bill SCR221

Introduced
3/11/22  
Refer
3/16/22  
Report Pass
4/1/22  
Engrossed
4/4/22  
Refer
4/4/22  
Report Pass
4/19/22  

Caption

Requesting The Legislative Reference Bureau To Conduct A Study On The Relationship Between The Current Prices Of And Access To Medical Cannabis And The Volume Of Illicit Cannabis Sales In The State.

Impact

The implications of SCR221 are substantial for state laws governing medical cannabis. Currently, only eight dispensary licenses are issued statewide, resulting in just sixteen retail locations available for the entire population of registered medical cannabis patients. With over two-thirds opting for illicit purchases, the study aims to gather data that could inform legislative changes to enhance access to legal cannabis while also addressing pricing disparities. The state's focus is on reducing the illegal market and promoting safe consumption through regulated access.

Summary

SCR221 is a Senate Concurrent Resolution from Hawaii that requests the Legislative Reference Bureau to conduct a study examining the relationship between the prices of medical cannabis, access to licensed dispensaries, and the volume of illicit cannabis sales in the state. This resolution arises from concerns that despite a regulated medical cannabis system established in 2015 through Act 241, a significant majority of registered medical cannabis patients still obtain their cannabis from illegal sources. This finding highlights potential issues of accessibility and affordability within the existing legal framework for medical cannabis.

Sentiment

The sentiment surrounding SCR221 reflects a recognition of the challenges faced by patients in Hawaii. Stakeholders generally agree on the need for improvement within the medical cannabis system; however, there are differing opinions about how best to achieve this. Supporters advocate for expanded access and reduced prices to encourage more patients to use licensed dispensaries, while skeptics may raise questions regarding the potential for oversaturation of the market or the implications for current dispensary operations.

Contention

Notable points of contention regarding SCR221 include concerns over the current legislated limits on dispensaries and the implications of any changes that may arise from the study's findings. Some worry that easing restrictions might lead to an influx of new dispensaries without ensuring sufficient market demand, while others emphasize the necessity of adapting the legislative framework to better meet patient needs. The resolution also paves the way for potential legislative proposals that could emerge from the findings of the study, making it a pivotal point for future discussions on cannabis policy in Hawaii.

Companion Bills

HI SR214

Same As Requesting The Auditor To Conduct A Study On The Relationship Between The Current Prices Of And Access To Medical Cannabis And The Volume Of Illicit Cannabis Sales In The State.

Similar Bills

HI HB477

Relating To Cannabis.

HI SB2273

Relating To Cannabis.

AZ SB1716

Medical marijuana; invalidity; exception

HI SB1332

Relating To Cannabis.

HI HB2260

Relating To Cannabis.

HI HB2335

Relating To Medical Cannabis.

AZ SB1105

Medical marijuana dispensaries; location

HI SB2461

Relating To Medical Cannabis.